BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25614306)

  • 1. Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
    Prasun P; Young S; Salomons G; Werneke A; Jiang YH; Struys E; Paige M; Avantaggiati ML; McDonald M
    JIMD Rep; 2015; 19():111-5. PubMed ID: 25614306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency.
    Smith A; McBride S; Marcadier JL; Michaud J; Al-Dirbashi OY; Schwartzentruber J; Beaulieu CL; Katz SL; ; Majewski J; Bulman DE; Geraghty MT; Harper ME; Chakraborty P; Lines MA
    JIMD Rep; 2016; 30():73-79. PubMed ID: 27306203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
    Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
    Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
    Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
    BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
    Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
    Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
    Pop A; Williams M; Struys EA; Monné M; Jansen EEW; De Grassi A; Kanhai WA; Scarcia P; Ojeda MRF; Porcelli V; van Dooren SJM; Lennertz P; Nota B; Abdenur JE; Coman D; Das AM; El-Gharbawy A; Nuoffer JM; Polic B; Santer R; Weinhold N; Zuccarelli B; Palmieri F; Palmieri L; Salomons GS
    J Inherit Metab Dis; 2018 Mar; 41(2):169-180. PubMed ID: 29238895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-2-hydroxyglutaric aciduria and glutaric aciduria type 1 in siblings: coincidence, or linked disorders?
    Korman SH; Salomons GS; Gutman A; Brooks R; Jakobs C
    Neuropediatrics; 2004 Jun; 35(3):151-6. PubMed ID: 15248096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiomics approach to understanding pathology of Combined D,L-2- Hydroxyglutaric Aciduria and phenylbutyrate as potential treatment.
    Phua YL; D'Annibale OM; Karunanidhi A; Mohsen AW; Kirmse B; Dobrowolski SF; Vockley J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestation of recessive combined D-2-, L-2-hydroxyglutaric aciduria in combination with 22q11.2 deletion syndrome.
    Eguchi M; Ozaki E; Yamauchi T; Ohta M; Higaki T; Masuda K; Imoto I; Ishii E; Eguchi-Ishimae M
    Am J Med Genet A; 2018 Feb; 176(2):351-358. PubMed ID: 29265763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the mitochondrial carrier,
    Kasprzyk-Pawelec A; Tan M; Rahhal R; McIntosh A; Fernandez H; Mosaoa R; Jiang L; Pearson GW; Glasgow E; Vockley J; Albanese C; Avantaggiati ML
    bioRxiv; 2024 May; ():. PubMed ID: 37503155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
    Majd H; King MS; Smith AC; Kunji ERS
    Biochim Biophys Acta Bioenerg; 2018 Jan; 1859(1):1-7. PubMed ID: 29031613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.
    Balaraju S; Töpf A; McMacken G; Kumar VP; Pechmann A; Roper H; Vengalil S; Polavarapu K; Nashi S; Mahajan NP; Barbosa IA; Deshpande C; Taylor RW; Cossins J; Beeson D; Laurie S; Kirschner J; Horvath R; McFarland R; Nalini A; Lochmüller H
    Eur J Hum Genet; 2020 Mar; 28(3):373-377. PubMed ID: 31527857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related metabolites in culture medium of fibroblasts from patients with D-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria, and combined D/L-2-hydroxyglutaric aciduria.
    Struys EA; Verhoeven NM; Roos B; Jakobs C
    Clin Chem; 2003 Jul; 49(7):1133-8. PubMed ID: 12816910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
    Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
    J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity in the presentation of D-2-hydroxyglutaric aciduria in monozygotic twins.
    Misra VK; Struys EA; O'brien W; Salomons GS; Glover T; Jakobs C; Innis JW
    Mol Genet Metab; 2005; 86(1-2):200-5. PubMed ID: 16081310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
    Chaouch A; Porcelli V; Cox D; Edvardson S; Scarcia P; De Grassi A; Pierri CL; Cossins J; Laval SH; Griffin H; Müller JS; Evangelista T; Töpf A; Abicht A; Huebner A; von der Hagen M; Bushby K; Straub V; Horvath R; Elpeleg O; Palace J; Senderek J; Beeson D; Palmieri L; Lochmüller H
    J Neuromuscul Dis; 2014; 1(1):75-90. PubMed ID: 26870663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-2-hydroxyglutaric aciduria. Report of two cases].
    Mahfoud A; Domínguez CL; Rashed M; Durán M; Rodríguez T; Rodríguez D; Landa V
    Invest Clin; 2009 Sep; 50(3):369-75. PubMed ID: 19961059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria.
    Haliloglu G; Temucin CM; Oguz KK; Celiker A; Coskun T; Sass JO; Fischer J; Topcu M
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S21-5. PubMed ID: 19169842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in understanding 2-hydroxyglutaric acidurias.
    Kranendijk M; Struys EA; Salomons GS; Van der Knaap MS; Jakobs C
    J Inherit Metab Dis; 2012 Jul; 35(4):571-87. PubMed ID: 22391998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial anomalies in D-2-hydroxyglutaric aciduria.
    Amiel J; de Lonlay P; Francannet C; Picard A; Bruel H; Rabier D; Le Merrer M; Verhoeven N; Jakobs C; Lyonnet S; Munnich A
    Am J Med Genet; 1999 Sep; 86(2):124-9. PubMed ID: 10449646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.